Delivery Order SPE2DB22D2009-SPE2DB25FM0MV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,576.30 in Mycophenolate 500 mg tablets (500-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,645.74 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg tablets (500-count units) on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price contract is unclassified and has no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg tablets (500-count units) valued at $5,782.51 with firm fixed pricing. This competitively awarded, non-set-aside contract is scheduled for completion by September 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger federal...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, to provide 160 ml bottles of Mycophenolate 200 mg/ml suspension. The $3,561.92 contract has a completion date of February 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this delivery order. No set-aside designation was used. Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,520.05 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of MYCOPHENOLATE 500 MG TABLET 500S to Conshohocken, PA. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of up...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mycophenolate, a 200 mg/mL suspension medication in a 160 mL volume, with a ceiling value of $4,296.18. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. No set-aside designation is mentioned, indicating this was an open competition....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $46,747.36 delivery order on September 8, 2025, for the supply of Atovaquone 750 mg/5 ml suspension in 210 ml quantities. This competitively awarded, firm fixed-price contract with no set-aside designation is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal procurement entity responsible for pharmaceutical and medical supply...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifty-one thousand, eight hundred one dollars to Amerisourcebergen Drug Corporation for one hundred capsules of the pharmaceutical mycophenolate. The prime contractor, a division of Amerisourcebergen Corporation, will deliver the products to a facility in Conshohocken, Pennsylvania by June 29, 2023 under a start date of June 28, 2023. The award draws from the DLA's pharmaceutical procurement programs to support...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $163,801.69 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, competitively awarded contract (no set-aside) is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0MVDelivery Order
The Defense Logistics Agency awarded a $4,296.65 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mycophenolate 200 mg/ml suspension in a 160 ml quantity, with completion targeted for July 28, 2025. This firm fixed price contract represents a non-competitive set-aside award to the pharmaceutical distributor's corporate office, with performance to be executed in Conshohocken, Pennsylvania, where the company maintains its headquarters. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical federal medical procurement vendor supplying medications, vaccines, and medical supplies across multiple therapeutic domains to military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of federal contract awards demonstrates consistent capability in fulfilling open competition procurement requirements through competitively awarded delivery orders with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 7/25/25 |